药物警戒中个例安全性报告的多智能体检索增强因果关系评估(MARCA)

arXiv cs.CL 论文

摘要

提出 MARCA 四智能体框架,利用 Gemini 2.5 Pro 和 DeepSeek-V3.2 结合检索增强生成(RAG)对 FAERS 个体案例安全报告进行基于 Naranjo 量表的因果关系评估,最终因果分类与人类专家的一致率达 79.4%(κ=0.587)。

arXiv:2610.33279v1 Announce Type: new Abstract: Introduction: Increasing volumes of individual case safety reports (ICSRs) challenge expert-led causality assessment in pharmacovigilance. We developed MARCA (Multi-Agent Retrieval-Augmented Causality Assessment), a four-agent framework for Naranjo-based assessment, and evaluated agreement with human experts and exploratory differences between non-RAG and RAG-labelled scores. Methods: MARCA combined scientific literature retrieval, drug-label assessment, objective-evidence classification, and clinical causality reasoning using Gemini 2.5 Pro and DeepSeek-V3.2. Agent-generated rationales informed human-assisted scoring. A consensus expert reference standard covered 215 ICSRs and 1,562 drug-event combinations (DECs) from FAERS (Q1-Q2 2025). Agreement was measured using percentage agreement and Cohen's kappa. Results: Question-level agreement was 96.8% for Naranjo Q2 (kappa = 0.491; 95% CI 0.265-0.663), 85.4% for Q5 (kappa = 0.269; 95% CI 0.180-0.340), and 96.8% for Q10 (kappa = 0.922; 95% CI 0.885-0.951). Final causality classification agreement was 79.4% (95% CI 71.8-85.3; kappa = 0.587, 95% CI 0.450-0.690). In a retrospective subset of 60 DECs, agreement was higher for RAG-labelled than non-RAG scores for Q5 (83.3% vs 65.0%) and Q10 (100.0% vs 18.3%). Discussion: MARCA-assisted assessment showed substantial variation in agreement across Naranjo questions, with lower concordance for alternative causes. Retrospective RAG comparisons are exploratory and do not establish prospective effectiveness.
查看原文
查看缓存全文

缓存时间: 2026/10/28 02:01

# Multi-Agent Retrieval-Augmented Causality Assessment (MARCA) of Individual Case Safety Reports in Pharmacovigilance
Source: [https://arxiv.org/abs/2610.33279](https://arxiv.org/abs/2610.33279)
[View PDF](https://arxiv.org/pdf/2610.33279)

> Abstract:Introduction: Increasing volumes of individual case safety reports \(ICSRs\) challenge expert\-led causality assessment in pharmacovigilance\. We developed MARCA \(Multi\-Agent Retrieval\-Augmented Causality Assessment\), a four\-agent framework for Naranjo\-based assessment, and evaluated agreement with human experts and exploratory differences between non\-RAG and RAG\-labelled scores\. Methods: MARCA combined scientific literature retrieval, drug\-label assessment, objective\-evidence classification, and clinical causality reasoning using Gemini 2\.5 Pro and DeepSeek\-V3\.2\. Agent\-generated rationales informed human\-assisted scoring\. A consensus expert reference standard covered 215 ICSRs and 1,562 drug\-event combinations \(DECs\) from FAERS \(Q1\-Q2 2025\)\. Agreement was measured using percentage agreement and Cohen's kappa\. Results: Question\-level agreement was 96\.8% for Naranjo Q2 \(kappa = 0\.491; 95% CI 0\.265\-0\.663\), 85\.4% for Q5 \(kappa = 0\.269; 95% CI 0\.180\-0\.340\), and 96\.8% for Q10 \(kappa = 0\.922; 95% CI 0\.885\-0\.951\)\. Final causality classification agreement was 79\.4% \(95% CI 71\.8\-85\.3; kappa = 0\.587, 95% CI 0\.450\-0\.690\)\. In a retrospective subset of 60 DECs, agreement was higher for RAG\-labelled than non\-RAG scores for Q5 \(83\.3% vs 65\.0%\) and Q10 \(100\.0% vs 18\.3%\)\. Discussion: MARCA\-assisted assessment showed substantial variation in agreement across Naranjo questions, with lower concordance for alternative causes\. Retrospective RAG comparisons are exploratory and do not establish prospective effectiveness\.

## Submission history

From: Maurizio Sessa Dr\. \[[view email](https://arxiv.org/show-email/3457f6c5/2610.33279)\] **\[v1\]**Fri, 23 Oct 2026 20:43:29 UTC \(2,619 KB\)

相似文章

知识增强型智能体AI用于心理健康药物信息查询

arXiv cs.AI

本文提出了一种具有来源感知能力、基于知识图谱的多智能体框架,该框架整合了来自Reddit和WebMD的患者叙事以及FDA针对九种抗抑郁药的药物不良事件报告,利用大语言模型(LLM)实体识别流水线实现了高准确率,并能够提供可追踪的精神科药物安全信息。

MAREval:用于评估自然语言推荐解释的多智能体框架

arXiv cs.AI

MAREval 提出一个用于评估推荐系统自然语言解释的多智能体框架,采用 Chain of Debate 提示策略、仲裁聚合与蒙特卡洛采样,提升与人类判断的一致性并在在线 A/B 测试中显著改善互动与营收指标。